Mantle Zone Lymphoma Refractory/Recurrent
1 clinical trials · Condition
◉ Watch Mantle Zone Lymphoma Refractory/Recurrent
| Record | Firm | Date |
|---|---|---|
| Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia (NCT02981745) | Centaurus Biopharma Co., Ltd. | 2017-04-01 |
Track Mantle Zone Lymphoma Refractory/Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.